These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 16978233)

  • 21. Atosiban vs ritodrine used prophylactically with cerclage in ICSI pregnancies to prevent pre-term birth in women identified as being at high risk on the basis of transvaginal ultrasound scan.
    Locci M; Nazzaro G; Merenda A; Pisaturo ML; Laviscio P; Poppiti R; Miranda M; Stile A; De Placido G
    J Obstet Gynaecol; 2006 Jul; 26(5):396-401. PubMed ID: 16846862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxytocin receptor antagonists for inhibiting preterm labour.
    Papatsonis D; Flenady V; Cole S; Liley H
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004452. PubMed ID: 16034931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
    Romero R; Sibai BM; Sanchez-Ramos L; Valenzuela GJ; Veille JC; Tabor B; Perry KG; Varner M; Goodwin TM; Lane R; Smith J; Shangold G; Creasy GW
    Am J Obstet Gynecol; 2000 May; 182(5):1173-83. PubMed ID: 10819855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No effect of tocolytic therapy with atosiban on maternal serum interleukin-6 and tumor necrosis factor-alpha in threatened preterm labor.
    Vitoratos N; Kountouris A; Makrakis E; Papadias K; Creatsas G
    J Matern Fetal Neonatal Med; 2007 Oct; 20(10):725-8. PubMed ID: 17763273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The development and introduction of anti-oxytocic tocolytics.
    Lamont RF
    BJOG; 2003 Apr; 110 Suppl 20():108-12. PubMed ID: 12763125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy side-effects and predictive factors for preterm delivery in patients undergoing tocolysis with atosiban or ritodrine for threatened preterm labour.
    Driul L; Londero AP; Adorati-Menegato A; Vogrig E; Bertozzi S; Fachechi G; Forzano L; Cacciaguerra G; Perin E; Miceli A; Marchesoni D
    J Obstet Gynaecol; 2014 Nov; 34(8):684-9. PubMed ID: 24959721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tocolytic therapy and clinical experience. Combination therapy.
    Ingemarsson I
    BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
    Kim A; Shim JY
    BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
    French/Australian Atosiban Investigators Group
    Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.
    Goodwin TM; Valenzuela GJ; Silver H; Creasy G
    Obstet Gynecol; 1996 Sep; 88(3):331-6. PubMed ID: 8752234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tocolysis. Atosiban, an ocytcin-receptor antagonist].
    Schmitz T; Cabrol D
    J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):238-45. PubMed ID: 11397999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow up of children exposed in utero to nifedipine or ritodrine for the management of preterm labour.
    Houtzager BA; Hogendoorn SM; Papatsonis DN; Samsom JF; van Geijn HP; Bleker OP; van Wassenaer AG
    BJOG; 2006 Mar; 113(3):324-31. PubMed ID: 16487205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atosiban versus betamimetics in the treatment of preterm labour in Italy: clinical and economic importance of side-effects.
    Wex J; Abou-Setta AM; Clerici G; Di Renzo GC
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):128-35. PubMed ID: 21620558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of oral nifedipine versus terbutaline injection in preterm labor.
    Laohapojanart N; Soorapan S; Wacharaprechanont T; Ratanajamit C
    J Med Assoc Thai; 2007 Nov; 90(11):2461-9. PubMed ID: 18181335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atosiban Combined with Ritodrine for Late Threatened Abortion or Threatened Premature Labor Patients with No Response to Ritodrine: A Clinical Trial.
    Fu S; Xie H; Zhong Y; Xu Q; Zhu L; Mo H; Zhang J; Liu Y; Chen H; Zhong Y; Tan J
    Med Sci Monit; 2021 Mar; 27():e929743. PubMed ID: 33731666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study.
    Morales WJ; Smith SG; Angel JL; O'Brien WF; Knuppel RA
    Obstet Gynecol; 1989 Oct; 74(4):567-72. PubMed ID: 2677863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of atosiban in a twin pregnancy with extremely preterm premature rupture in the membrane of one twin: a case report and literature review.
    Wu MY; Chen SU; Lee CN; Ho HN; Yang YS
    Taiwan J Obstet Gynecol; 2010 Dec; 49(4):495-9. PubMed ID: 21199753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of preterm labor with the oxytocin antagonist atosiban.
    Goodwin TM; Valenzuela G; Silver H; Hayashi R; Creasy GW; Lane R
    Am J Perinatol; 1996 Apr; 13(3):143-6. PubMed ID: 8688103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of clinical experience with atosiban and the Tractocile Efficacy Assessment Survey in Europe (TREASURE) study protocol.
    Husslein P; Quartarolo JP
    Int J Clin Pract; 2003 Mar; 57(2):121-7. PubMed ID: 12661796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.